SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is seeing active discussion as a highly speculative asset, with its community anticipating a significant price surge driven by broader market liquidity and accumulation efforts, while a strong bearish contingent predicts further price declines.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE is experiencing renewed bullish momentum, with the community actively accumulating during dips and anticipating significant price appreciation, driven by a broader return of liquidity to the memecoin sector.

Peoples Reserve leads the charge in financial innovation, harnessing Bitcoin's power as an engineered sound money to deliver revolutionary tools that redefine wealth building.  Peoples Reserve’s flagship products include:  Bitcoin Powered Mortgage (BPM) - A seller-financing installment contract-for-deed that dual collateralizes property title and Bitcoin to secure the debt. Borrowers post BTC collateral with no price-volatility based liquidation risk. Instead, every ten percent move in BTC price adjusts the interest rate, up or down in a 30-day period, based on the borrower's LTV. Buy a house, sleep without getting margin called, and watch your interest rate (cost of capital) decrease over time as the compounding growth of your pristine collateral strengthens your LTV. Available in all 50 U.S. states.   Bitcoin Bond - A financially engineered principal-protected note designed to eliminate nominal investment value risk while maximizing yield potential. This is accomplished by packaging together U.S. Treasuries with Bitcoin based on a dynamic allocation model applied at issuance. This means that even if Bitcoin goes to zero, the nominal value of the investment is secured by the full faith and credit of the U.S. federal government. If Bitcoin continues to produce positive compounding annual growth rates, the Bitcoin Bond becomes the best performing risk-adjusted cash flow vehicle in the world. Furthermore, use Bitcoin Bonds as pristine collateral on the Peoples Reserve platform to take out a line of credit with no liquidation risk.  At its core, Peoples Reserve views Bitcoin as more than just a store of value or payment method — it's the ultimate financial layer. As the world's most pristine form of collateral, Bitcoin underpins the fusion of traditional financial tools with decentralized security.   Peoples Reserve builds these superior tools using sound money (Bitcoin, Gold &amp; Silver) as the equity-backed collateral foundation layer. This means lower risk for lenders and sustainably lower interest rates for borrowers; creating a future of finance that supports tomorrow's AI driven economy.   With Sound Money Finance, Peoples Reserve helps you Build Wealth Smarter.

Peoples Reserve

Peoples Reserve ($PRN) is trending due to strong community excitement surrounding its high utility, positioning itself as a disruptor in real estate and finance by leveraging Bitcoin as collateral. Discussions highlight its potential for calculable economic benefits, including lower borrowing costs and increased yields, with an anticipated Q2 launch.

Literally a dog wif a hat, dogwifhat (WIF) is a meme coin that's part of the ever-growing ecosystem of digital currencies on the Solana blockchain. This token brings a lighthearted twist to cryptocurrency, featuring a playful dog with a hat as its mascot, symbolising a more whimsical approach to the often serious domain of digital finance.

dogwifhat

Dogwifhat (WIF) is trending amid highly polarized sentiment, with many in the community expressing frustration over consistent price declines and sideways movement, while others remain bullish, buying dips, and anticipating a significant rebound, with "the hat staying on" as they eye a return to the $1.00 mark and beyond.

Victoria's Secret & Co. operates as a lingerie, clothing and beauty retailer. It offers bras, panties, lingerie, pajamas, sleep, sport and swim apparel, and beauty products. The company was founded in 1963 and is headquartered in Reynoldsburg, OH.

Victoria`s Secret & Co

Victoria's Secret is trending after reporting stronger-than-expected earnings and raising its full-year guidance, which is driving a narrative of a brand comeback. Despite this positive financial momentum, community discussions highlight lingering concerns about the company's brand image and recent activist investor interest.

Viper Energy, Inc. engages in the acquisition of oil and natural gas properties. It owns, acquires, and exploits oil and natural gas properties in North America. The company is headquartered in Midland, TX.

Viper Energy Inc - Ordinary Shares - Class A

Viper Energy Partners LP

Viper Energy Partners is trending due to a flurry of recent analyst upgrades and increased price targets, alongside its strategic pivot to further concentrate on core Permian Basin assets. The community sees VNOM as an undervalued income play with strong fundamentals, poised to benefit from robust energy demand and continued operational execution.

Willow Lane Acquisition Corp. is a blank check company, which engages for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on July 3, 2024 and is headquartered in New York, NY.

Willow Lane Acquisition Corp. - Ordinary Shares - Class A

WLAC is trending due to its imminent de-SPAC merger with AI cloud infrastructure provider Boost Run, following the recent S-4 filing and upcoming merger vote. The community is highly bullish, citing Boost Run's massive projected revenue growth, strategic partnerships, and position in the red-hot AI data center sector, with many anticipating a significant run-up for this low-float stock.

Yearn Finance is a suite of products in Decentralized Finance (DeFi) that provides lending aggregation, yield generation, and insurance on the Ethereum blockchain. The protocol is maintained by various independent developers and is governed by YFI holders.  It started out as a passion project by Andre Cronje to automate the process of switching capital between lending platforms in search of the best yield offered, as the lending yield is a floating rate rather than fixed rate. Funds are shifted between dYdX, AAVE, and Compound automatically as interest rates change between these protocols.   The service offered includes major USD tokens such as DAI, USDT, USDC, and TUSD. For example, if a user deposits DAI into yearn.finance, the user will receive yDAI token in return, which is a yield-bearing DAI token.   Later on, it collaborated with Curve Finance to release a yield-bearing USD tokens pool that includes four y-tokens: yDAI, yUSDT, yUSDC and yTUSD, it is named as yUSD.   Yearn Finance debuted the vault feature after its token launch, igniting a frenzy on automated yield farming and is considered the initiator of the category of yield farming aggregator. Basically, the vault will help users to claim yield farming rewards and sell it for the underlying assets.   Vaults benefit users by socializing gas costs, automating the yield generation and rebalancing process, and automatically shifting capital as opportunities arise. End users also do not need to have proficient knowledge of the underlying protocols involved or DeFi, thus the Vaults represent a passive-investing strategy. It is akin to a crypto hedge fund where the aim is to increase the amount of assets that users deposited.

yearn.finance

Yearn.finance (YFI) is trending with intense community speculation about its potential for a massive price surge, primarily driven by its extremely limited token supply and a renewed focus on the decentralized finance (DeFi) sector. Many view YFI as severely undervalued, poised for significant upside as declining interest rates are anticipated to boost DeFi activity and broader crypto market momentum continues.

TOSHI

TOSHI is trending as the crypto community actively debates the start of 'meme coin season,' with many rallying behind its identity as the 'face of Base' ecosystem. While some express caution, strong bullish sentiment persists, with holders anticipating significant upward movement and closely observing Bitcoin's market influence for further catalysts.

Valero Energy Corp. engages in the manufacture and marketing of transportation fuels and other petrochemical products. It operates through the following business segments: Refining, Ethanol and Renewable Diesel. The Refining segment consists of refining operations, associated marketing activities, and logistics assets that support its refining operations. The Ethanol segment includes its ethanol operations, associated marketing activities, and logistics assets that support its ethanol operations. The Renewable Diesel covers the operations of Diamond Green Diesel Holdings LLC. The company was founded in 1980 and is headquartered in San Antonio, TX.

Valero Energy Corp.

Valero Energy is trending as the market anticipates significant gains from its capacity to process newly accessible Venezuelan heavy crude, a perfect fit for its Gulf Coast refineries, with investors actively discussing how this, combined with strong refining margins, positions the company for enhanced profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Seres Therapeutics (NASDAQ:MCRB) Rating Lowered to Sell at Wall Street Zen

Wall Street Zen downgraded shares of Seres Therapeutics from a "hold" rating to a "sell" rating in a research report on Saturday...

<ul class="summary-bullets"><li>Seres said the pause follows the completion of study site evaluation and qualification work with its contract research organization.</li><li>The company said following the pause in additional investment into the SER-155 Phase 2 study, it will shift its operational focus to high-value earlier-stage pipeline programs.</li><li>Seres noted that its cost-cutting measures are expected to extend its cash runway into the third quarter of 2026.</li></ul>Seres Therapeutics Inc. (MCRB) shares fell more than 21% in Thursday’s pre-market trade after the company announced that it is pausing a planned Phase 2 study, while reducing the headcount by 30% to extend its cash runway.Seres stated that it has finalized the protocol for the Phase 2 study of SER-155 in patients undergoing allogeneic hematopoietic stem cell transplant (allo-HSCT) with the U.S. Food and Drug Administration (FDA).“As we pursue earlier stage programs with the greatest opportunity, such as those targeting inflammatory bowel disease (IBD), we are exploring collaborations to provide additional capital to the company,” said Thomas DesRosier and Marella Thorell, co-CEOs of Seres.<h2 class="st-heading-2">Why Did Seres Pause The Study?</h2>Seres said the pause follows the completion of study site evaluation and qualification work with its contract research organization, adding that the Phase 2 study drug substance has already been manufactured.The company said that following the pause in additional investment into the SER-155 Phase 2 study, it will shift its operational focus to high-value earlier-stage pipeline programs. At the same time, it will continue to seek funding for the Phase 2 study, Seres said.<h2 class="st-heading-2">Extending Cash Runway</h2>Seres noted that its cost-cutting measures, including workforce reductions, are expected to extend its cash runway into the third quarter (Q3) of 2026.The company said that this will help in supporting the continued development of its programs for inflammatory and immune-related diseases, while also giving it additional time to secure funding for the SER-155 Phase 2 study.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/MCRB">Seres Therapeutics</a> trended in the ‘bullish’ territory at the time of writing, with message volumes at ‘high’ levels.One user on Stocktwits said that Seres’ announcement confirms that “there is no one interested to partner” with the company.<stembedurl>https://stocktwits.com/Kenny1207/message/644771398</stembedurl><a href="https://stocktwits.com/symbol/MCRB">MCRB stock</a> is down 51% year-to-date and 75% over the past 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/samsung-ships-world-first-commercial-hbm4-memory-module-ai-computing/cZRTlXNR4ra">Samsung Ships First Commercial HBM4 Memory Module, Nvidia’s Vera Rubin Expected To Use It: SSNLF Stock Soars 55%</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Seres Therapeutics biotechnology company building, Cambridge, Massachusetts, USA

MCRB Stock Declines As Seres Therapeutics Pauses SER-155 Phase 2 Study And Shrinks Headcount By 30%

The company said that it will continue to seek funding for the SER-155 Phase 2 study.

Equity

Seres Therapeutics (NASDAQ:MCRB) Stock Price Passes Below 50-Day Moving Average - Time to Sell?

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below Fifty Day Moving Average - Here's What Happened...

Seres Therapeutics (NASDAQ:MCRB) Shares Cross Below 50-Day Moving Average - Here's What Happened

Seres Therapeutics (NASDAQ:MCRB) Shares Cross Below 50-Day Moving Average - Here's What Happened...

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 50 Day Moving Average - Time to Sell?

Seres Therapeutics (NASDAQ:MCRB) Share Price Passes Below 50-Day Moving Average - What's Next...

Seres Therapeutics (NASDAQ:MCRB) Stock Price Passes Below 50-Day Moving Average - Here's Why

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 50-Day Moving Average - Here's Why...

3 Beaten-Down Biotech Stocks to Buy for a 2026 Turnaround

Beaten-down biotech stocks like ALT, IBRX and MCRB are eyeing a 2026 rebound as FDA alignment, pipeline progress and approvals fuel optimism.

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below 50 Day Moving Average - Should You Sell?

Seres Therapeutics (NASDAQ:MCRB) Stock Crosses Below Fifty Day Moving Average - Should You Sell...

Seres Therapeutics (NASDAQ:MCRB) Stock Price Crosses Above 50 Day Moving Average - Here's What Happened

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Above Fifty Day Moving Average - What's Next...

Seres Therapeutics (NASDAQ:MCRB) Stock Passes Below 50 Day Moving Average - Here's What Happened

Seres Therapeutics (NASDAQ:MCRB) Shares Pass Below Fifty Day Moving Average - Here's Why...

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.

Seres Therapeutics Inc

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$2.11	--	--	N/A
Q3 '25	$0.46	$0.94	105.84%	BEAT
Q2 '25	-$2.49	-$2.27	8.84%	BEAT
Q1 '25	$0.10	$3.75	3575.46%	BEAT
Q4 '24	-$0.20	-$1.80	-816.00%	MISSED

MCRB
Seres Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest MCRB News

MCRBSeres Therapeutics Inc